4//SEC Filing
Plesha Scott M. 4
Accession 0001103021-22-000016
CIK 0001103021other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 5:56 PM ET
Size
19.3 KB
Accession
0001103021-22-000016
Insider Transaction Report
Form 4
Plesha Scott M.
President
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-01-27−21,050→ 42,101 totalExercise: $0.00Exp: 2024-01-27→ Common Stock (21,050 underlying) - Exercise/Conversion
Common Stock
2022-01-27+21,050→ 320,924 total - Exercise/Conversion
Common Stock
2022-01-31+10,869→ 331,793 total - Exercise/Conversion
Common Stock
2022-01-31+13,334→ 345,127 total - Award
Stock Options (right to buy)
2022-01-27$3.66/sh+369,721$1,353,179→ 369,721 totalExercise: $3.66Exp: 2032-01-26→ Common Stock (369,721 underlying) - Exercise/Conversion
Restricted Stock Units
2022-01-29−10,869→ 10,870 totalExercise: $0.00Exp: 2023-01-29→ Common Stock (10,869 underlying) - Exercise/Conversion
Restricted Stock Units
2022-01-31−13,334→ 0 totalExercise: $0.00Exp: 2022-01-31→ Common Stock (13,334 underlying) - Award
Restricted Stock Units
2022-01-27+66,257→ 66,257 totalExercise: $0.00Exp: 2025-01-27→ Common Stock (66,257 underlying)
Footnotes (7)
- [F1]The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on January 27, 2022.
- [F2]The stock options were issued to the Reporting Person on January 27, 2022, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (the "Plan"). The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2023; (ii) January 27, 2024; and (iii) January 27, 2025.
- [F3]The Restricted Stock Units ("RSUs") were issued to the Reporting Person on January 27, 2022, pursuant to a grant under the Plan. The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2023; (ii) January 27, 2024; and (iii) January 27, 2025.
- [F4]Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock.
- [F5]The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on January 27, 2021, under the Plan. The remaining RSUs will vest in equal portions on: (i) January 27, 2023; and (ii) January 27, 2024.
- [F6]The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on January 29, 2020, under the Plan. The remaining RSUs vest on January 29, 2023.
- [F7]The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on January 31, 2019, under the Issuer's 2011 Equity Incentive Plan.
Documents
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
CIK 0001103021
Entity typeother
Related Parties
1- filerCIK 0001726687
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 5:56 PM ET
- Size
- 19.3 KB